what's the difference between semaglutide and ozempic Wegovy vs. Ozempic: What To Know Ozempic & Wegovy (Semaglutide) Weight

If eventually, the ice packs melt and are no longer cold, semaglutide can be kept at room temperature (up to 86F or 30C) for a limited time (up to 28 days)

Hydration Drink more water than you think you need

This helps with hunger control, blood sugar, and fat loss

Standard Cagrilintide Monotherapy Protocol Phase 1: Initiation (Weeks 1-2) Dose: 0.6 mg once weekly Goal: Establish tolerance to amylin activation Expected effects: Mild appetite reduction, possible mild nausea Adjustments: Extend this phase if significant GI effects occur Phase 2: First Escalation (Weeks 3-4) Dose: 1.2 mg once weekly Goal: Increase therapeutic effect Expected effects: Notable appetite suppression, improved satiety Adjustments: May stay at this dose if excellent results achieved Phase 3: Second Escalation (Weeks 5-8) Dose: 2.4 mg once weekly Goal: Approach optimal therapeutic range Expected effects: Significant appetite control, steady weight loss Adjustments: Many researchers find this dose optimal long-term Phase 4: Optimization (Weeks 9-12) Dose: 3.0 mg once weekly Goal: Maximize therapeutic benefit Expected effects: Peak appetite suppression Adjustments: Only escalate if 2.4 mg insufficient and well-tolerated Phase 5: Maintenance (Week 13+) Dose: 3.0-4.5 mg once weekly Goal: Sustain long-term effects Expected effects: Stable appetite control and weight management Adjustments: Find minimum effective dose for maintenance Cagrilintide Dosage with Retatrutide: Combination Protocol When combining cagrilintide with retatrutide, a more conservative escalation approach minimizes overlapping side effects: Weeks 1-2: Single Agent Start Cagrilintide: 0.6 mg weekly Retatrutide: None (or 0.6 mg if starting both) Rationale: Establish tolerance to one compound first Weeks 3-4: Gentle Combination Cagrilintide: 0.6-1.2 mg weekly Retatrutide: 2 mg weekly Rationale: Introduce second compound at low dose Weeks 5-8: Dual Escalation Cagrilintide: 1.2-2.4 mg weekly Retatrutide: 4 mg weekly Rationale: Gradually increase both compounds Weeks 9-12: Therapeutic Range Cagrilintide: 2.4 mg weekly Retatrutide: 6-8 mg weekly Rationale: Approach optimal combination dosing Weeks 13+: Optimized Maintenance Cagrilintide: 2.4-3.0 mg weekly Retatrutide: 8-12 mg weekly Rationale: Maintain therapeutic effects long-term Researchers can access properly dosed cagrilintide 10mg vials that allow flexible dosing across this range

Hypoxic exposure significantly reduces VE-cadherin expression, leading to increased endothelial permeability

Topical formulations Serum : Most common, 1-3% GHK-Cu concentration Cream : Heavier, good for dry skin, 0.5-2% concentration Patches : Copper peptide patches deliver sustained release, convenient DIY : Some make their own from powder (advanced users) Commercial products : Many skincare brands offer GHK-Cu serums Topical application Frequency : Apply 2x daily (morning and evening) Amount : 2-3 drops serum or pea-sized amount cream Application sites : Face and neck (anti-aging) Under eyes (fine lines, dark circles) Hands (age spots, wrinkles) Any area with skin concerns Process : Cleanse skin Apply to slightly damp skin Pat gently, don't rub aggressively Let absorb (2-3 minutes) Follow with moisturizer if needed Timing : Morning application + evening application for best results Topical vs injectable for skin Topical advantages : Less expensive ($30-60 per month) No injection skill needed Direct application to target area Convenient daily use Injectable advantages : Systemic benefits (not just skin) Higher bioavailability Anti-inflammatory effects throughout body Better for deep skin layers Best approach : Combine both for maximum skin results (topical + 1mg daily injectable) Expected results timeline 4-6 weeks : Improved skin texture, slight glow 8-12 weeks : Reduced fine lines, better firmness 4-6 months : Significant wrinkle reduction, improved elasticity, even tone Long-term : Continued improvement with consistent use Realistic expectations : Not Botox-level immediate results